Partnering
Together we can shape the future of healthcare
:quality(90)/)
Roche acquires 89bio and strengthens its presence in the obesity space
This includes an FGF21 analog in phase 3 for the therapy of moderate to severe stages of MASH.
Read the announcement media releaseRead the transaction closing media release
We are passionate about advancing science – no matter where it comes from. We identify the best innovations, whether internal or external, and delivering them to patients. Only by partnering with the brightest minds in science and healthcare, can we serve patients with difficult-to-treat diseases, both now and in future.
Partnering with Pharma
>250 active global partnerships
50% of the medicines we brought to patients in the last decade were touched by a partner
130 people worldwide focused on bringing in and managing lasting partnerships
Partnering with Diagnostics
53 new collaboration agreements in 2024
24 acquisitions since 2014
20+ years of partnering with companies and research institutes worldwide
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)